Lilly Zyprexa Patent Upheld On All Counts
This article was originally published in The Pink Sheet Daily
Executive Summary
The district court ruling means that generic versions of olanzapine are unlikely to enter the market before 2011, when the only "Orange Book" listed patent for Zyprexa is set to expire.
You may also be interested in...
Chinese Pharma Company Launches Generics Of Lilly's Zyprexa
SHANGHAI - Hansenpharm Co. began selling generic versions of Lilly's blockbuster antipsychotic Zyprexa (olanzapine) in China this month after winning a groundbreaking lawsuit against Lilly late last year
Chinese Pharma Company Launches Generics Of Lilly’s Zyprexa
Legal approach by Chinese firm could serve as roadmap for future patent disputes, lawyer tells PharmAsia News.
Chinese Pharma Company Launches Generics Of Lilly’s Zyprexa
Legal approach by Chinese firm could serve as roadmap for future patent disputes, lawyer tells PharmAsia News.